Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in Rheumatoid Arthritis
NCT05671497Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in rheumatoid arthritis (RA), sponsored by Ain Shams University. Started Nov 2022; status: completed.
02
Drugs
cilostazol
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05671497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05671497.